Editing the epigenome: Curing SYNGAP1 heterozygosity

Awardee: Elizabeth Heller

Institution: University of Pennsylvania

Grant Amount: $65,705.00

Funding Period: February 1, 2023 - January 31, 2024


Summary:

SynGAP1 syndrome occurs when a child is born with only one functional copy of the SynGAP1 gene. One approach to correct and cure this syndrome is to further activate the functional copy of the SynGAP1 gene, in order to compensate for the mutated copy. A major benefit of this approach is that it is independent of the specific mutation on the dysfunctional copy, and therefore can be utilized by all children with SynGAP1 syndrome. In order to develop a therapy that activates the functional copy of the SynGAP1 gene, we will first uncover the cellular mechanisms that govern SynGAP1 gene activation. Next we will develop tools to artificially activate SynGAP1 in the brain. Our goal is to design an intervention that is functional at all stages of development, for all SynGAP1 children.

Previous
Previous

Pain and Analgesic Mechanisms in a Mouse Model of Fibrous Dysplasia

Next
Next

Brain Penetrant Therapeutic Proteins for SETBP1 Haploinsufficiency Disorder